MBNL1 and myotonic dystrophy type 1: In 2020, cell studies shown that gain-of-function of MBNL1 could reverse the proliferation defect of skeletal muscle satellite cells in DM1 by inhibiting autophagy via the mTOR pathway (Song et al., 2020).